Skin

The University of Texas System is a leading public university system in the United States, dedicated to improving lives through education, health care, and research. With over 256,000 students enrolled across 14 institutions, the UT System is committed to providing affordable access to higher education and producing a skilled workforce to drive Texas's economy.

The Advanced Regenerative Manufacturing Institute (ARMI) is a member-based, nonprofit organization dedicated to advancing the bioeconomy of the United States. Its mission encompasses enhancing manufacturing, healthcare, and education and workforce development, aiming to create a scalable and effective manufacturing ecosystem for engineered cells, tissues, and organs.

Georgia Southern University is a vibrant institution with over 26,100 students across three campuses in Statesboro, Savannah, and Hinesville. The university offers 132 degree programs at the associate, bachelor’s, master’s, and doctorate levels, emphasizing student success, community impact, and research excellence. With a commitment to inclusivity and engagement, Georgia Southern fosters a supportive environment for diverse learners, including military-affiliated and adult students. The university is dedicated to transforming lives through education and community engagement, aligning its programs with regional needs. Additionally, Georgia Southern provides accelerated pathways for students to fast-track their master's degrees, enhancing educational opportunities. The university also emphasizes career readiness and public impact research, preparing students for successful careers and contributing to community development.

FiteBac Technologies/FiteBac Pharma's K21 uniquely targets the underlying disease state, given that most diseases involve microbial-associated inflammation and mitochondrial dysfunction. FiteBac Technology innovations stem from the work of numerous international academic research scientists. FiteBac Pharma K21 is the blockbuster antimicrobial small molecule designed to modulate biological, immunological, and metabolic systems for treating a wide range of infectious and inflammatory diseases. This patented drug substance has demonstrated the ability to safely eliminate bacterial, fungal, and viral infections, enhance innate immunity, induce mitophagy while improving mitochondrial and cellular metabolism, accelerate wound healing, and even promote the development of zebrafish and chickens, leading to increased adult mass. Rigorous research from Dr. Bhupesh Prusty's laboratory and Dr Christopher Rongo's laboratory is focused on various aspects of mitochondrial remodeling and reprograming, as well as mitochondrial-to-nuclear signaling with K21.

Lysando AG is a biopharmaceutical company specialized in antimicrobial protein technologies for combating pathogenic bacteria, particularly resistant and persistent strains. With a core focus on addressing antimicrobial resistance while preserving the human microbiome, the company develops protein-based therapeutic platforms for wound care, dermatology, and broader bacterial infection control. Lysando's solutions aim for effective pathogen management with low risk of resistance development, supporting sustainability and patient-centered healthcare outcomes.

The University of Texas at San Antonio (UTSA) is dedicated to the advancement of knowledge through research, teaching, and community engagement. As a premier public research university, UTSA embraces multicultural traditions and serves as a catalyst for socioeconomic development, providing access to educational excellence and preparing citizen leaders for the global environment.

SolasCure is dedicated to transforming chronic wound care through innovative therapeutic solutions. The company is at the forefront of developing Aurase Wound Gel, a breakthrough enzymatic debrider designed to return chronic wounds to healing. SolasCure aims to shift the paradigm in wound care by providing high-impact, safe, and effective treatments that address the underlying causes of wounds rather than just managing symptoms. With a strong focus on research and development, SolasCure is committed to improving the health and wellbeing of patients worldwide.

Auburn University Research & Economic Development is dedicated to advancing research and economic growth through a collaborative effort among its various colleges and departments. The organization focuses on fostering innovation, supporting faculty and student research, and facilitating partnerships with industry and government to address societal challenges and enhance the quality of life. Recent initiatives include the launch of the Team Science Series to promote interdisciplinary collaboration and the development of the Gulf Coast Engineering Research Station to address coastal environmental challenges.

SanaHeal is dedicated to developing next-generation bioadhesive technologies inspired by nature to solve significant challenges in healthcare. Their innovative solutions are designed to adhere to wet and uneven surfaces, providing rapid and robust adhesion for various medical applications.

SERDA Therapeutics is a clinical stage biopharmaceutical company focused on developing innovative solutions for wound care, particularly in the treatment of burn injuries and chronic ulcers. The company aims to provide fast and effective therapeutic debridement through its proprietary enzymatic product, SN514, which is designed to enhance healing by selectively removing necrotic tissue.

The Institute for Integrative & Innovative Research (I³R) at the University of Arkansas is dedicated to pioneering solutions to wicked problems and societal challenges through convergence research. With a mission to advance research excellence and stimulate economic development, I³R focuses on deploying innovations at scale through collaboration across various sectors, including academia, industry, and government.

UTMB is dedicated to supporting research, education, and scholarly endeavors, with a focus on creating the future of healthcare through innovative research and community engagement.

Spartan Medical is a medical solutions company serving VA medical centers, Department of Defense (DoD) facilities, civilian hospitals, and ambulatory surgery centers across the United States and internationally. The company specializes in advanced medical devices, surgical solutions, and support services, with a history of adapting to emergent healthcare challenges and logistical demands. Spartan Medical has provided solutions in public health crises, such as COVID-19 mitigation, and delivers comprehensive procurement, logistical, and operational support for healthcare organizations. It operates as a certified Service-Disabled Veteran-Owned Small Business (SDVOSB) and is recognized for its significant presence in federal healthcare contracting.

The University of Chicago is a prestigious urban research university committed to rigorous inquiry and intellectual freedom. Founded in 1890, it has produced numerous Nobel laureates and is known for its transformative education and groundbreaking research across various fields. The university fosters an inclusive and diverse learning environment, encouraging participation from all community members.

Boston University is a major research institution committed to leading breakthroughs across various disciplines. The Office of Research supports and advances research excellence, fostering collaboration among researchers, industry partners, and government leaders to address significant societal challenges.

ETC Innovation is a vertically integrated MedTech development company specializing in the design, development, and manufacturing of advanced wound dressing materials, antimicrobial substrates, and infection control products. The company brings together expertise in materials science, manufacturing processes, and regulatory compliance, offering solutions from concept through production for the medical industry. ETC Innovation operates a US-based facility supporting pilot to commercial-scale production, with a focus on custom materials for wound care and infection control. The company invests in R&D and holds equity in several early-stage medical device companies, and it provides proprietary material formulations, process development, and confidential research partnerships.

Baylor University is a preeminent Christian research university committed to addressing the world's most meaningful challenges through top-tier research and scholarship. Recognized as an R1 research institution, Baylor focuses on infusing its distinct Christian mission into its research initiatives, fostering a commitment to excellence and innovation.

California-based medical-device company developing topical and device-based treatments for acute and chronic wounds. Its work focuses on tissue surrounding wounds and on neuropathy-related, vascular, and other biological factors associated with impaired tissue repair.

Entropia Labs focuses on advancing functional medicine and wellness therapeutics through AI-driven molecular design and delivery technologies. The company aims to close the gap between promising treatments and rigorous scientific validation, with an emphasis on health-span extension.

Kane Biotech is a Canadian-based biotechnology company focused on the research, development, and commercialization of products that prevent and remove microbial biofilms. Established in 2001, the company aims to improve human and animal welfare through innovative solutions to biofilm-related challenges and antimicrobial resistance. With a strong portfolio of 54 patents and patents pending, Kane Biotech is recognized as a leader in biofilm research and technology, and is listed on the TSX Venture Exchange under the symbol 'KNE' and on the OTC Markets under the symbol 'KNBIF'.

NuShores Biosciences LLC, founded in 2014, is dedicated to commercializing patented bone and tissue regeneration technologies developed at the University of Arkansas at Little Rock. The company aims to improve the quality of life for individuals with severe tissue regeneration needs through innovative solutions like the NuCress™ bone scaffold technology, which is designed to promote healing in large segmental bone defects.

Exponent is a multidisciplinary science and engineering consulting firm serving sectors including healthcare, energy, manufacturing, and consumer products. From medical devices, pharmaceuticals, and supplements to digital health and wearables, we deliver rigorous science that quantifies impacts on human health. Exponent helps you push the envelope on the development, deployment, safety, and effectiveness of cutting-edge drugs, devices, and diagnostics — concomitantly balancing benefits and risks. Count on our multidisciplinary, data-driven, evidence-based assessments to give you clarity on your most complex product needs and challenges. With lives on the line, innovations that support healthcare demand the highest levels of scientific rigor. Whether you’re developing a novel drug, a sturdier stent, or a faster flu test, you need clear answers to complex questions, quickly. Exponent supports our life sciences clients across the total product lifecycle by solving critical design, regulatory, safety, and market access challenges. We can collaborate with you throughout your journey, helping you navigate risks and opportunities — and optimize outcomes — with science-based strategies and specialized expertise.

GelSana Therapeutics develops biomaterial-based wound dressings using zwitterionic polymer technology to address excessive inflammation and promote accelerated healing of chronic, surgical, and burn wounds. Founded in 2020, the company applies engineering and scientific research to produce advanced, stretchable, and moisture-managing wound care solutions designed to improve patient outcomes. Our first product CleraFlex, launched clinically in April 2026, is designed to address multiple factors in the wound healing cascade in a single drug-free product: inflammation, infection, and moisture management.

Clear Choice Therapeutics specializes in advanced wound care, with a focus on negative pressure wound therapy (NPWT) systems designed by orthopedic surgeons for both civilian and military applications. The company has developed FDA-cleared dressing kits and contact layers using proprietary transparent thermoplastic elastomer materials. Its NPWT solutions emphasize efficient fluid evacuation, enhanced wound visualization, reduced pain during dressing changes, and decreased infection risk—offering improvements over traditional foam-based wound therapies. The PREVENT allows for Low Pressure Wound Therapy (-50mmHg) which avoids high suction levels. Traditional foam NPWT can result in high downward forces on wounds resulting in decreased tissue perfusion and delayed healing.

Limax Biosciences is dedicated to revolutionizing tissue healing through innovative biomaterials inspired by the natural slime of slugs. Their hydrogels provide superior adhesion and healing capabilities, addressing unmet medical needs both inside and outside the body.

PVP Labs is a biotechnology company focused on the research, development, and commercialization of peptide-based therapeutics for pain management, viral infections, and wound care. The company delivers expertise in molecular research, drug development, laboratory diagnostics, and clinical trial execution, supporting healthcare and life sciences partners from its offices in Singapore and the USA.

SilkMed develops advanced wound care technologies using silk fibroin biomaterials. The company focuses on applying silk fibroin's biocompatibility, controlled degradation, and therapeutic delivery properties to create innovative solutions for wound management and healing through their spray device. SilkMed is currently developing a sprayable silk-biomaterial dressing that fully conforms to complex wound geometries for use in clinical and austere environments.

Solventum is a healthcare company dedicated to enabling better, smarter, and safer healthcare solutions. With a legacy of innovation, Solventum focuses on improving patient outcomes through advanced medical technologies, oral care solutions, health information technology, and purification and filtration systems.

The UT Arlington Research Institute (UTARI) specializes in applying cutting-edge technologies to real-world engineering problems. Our collaborative endeavors reflect a commitment to excellence, integrity, and respect for all, bringing economic growth and fulfillment to our families, business partners, university, and community.

RION is a clinical-stage regenerative medicine company based in Rochester, MN, focused on revolutionizing exosome science to heal from within. Established in 2017, RION leverages the unique properties of exosomes derived from platelets to develop innovative therapies aimed at enhancing tissue regeneration and addressing various medical challenges.

Flen Health develops, manufactures, and distributes advanced biotechnological solutions for wound and skin healing. Its offerings include topical dressings, gels, cleansers, and educational resources for both clinical professionals and patients. Operating globally in over 40 countries, Flen Health emphasizes research-driven product development, clinical education, and international collaboration to promote inclusive and effective wound care.

The University of Maryland, Baltimore (UMB) is Maryland’s public health, law, and human services university. It is dedicated to improving the human condition and serving the public good through education, research, clinical care, and service. UMB is the founding campus of the University System of Maryland and offers a wide range of professional degrees in health care, human services, and law.

The University of North Carolina Wilmington (UNCW) is a top doctoral and research institution located in Wilmington, North Carolina. Established in 1947, UNCW has grown to serve nearly 18,000 students and employs about 2,500 staff. The university is dedicated to providing a powerful academic experience that fosters creative inquiry, critical thinking, and thoughtful expression in a beautiful coastal setting. UNCW is committed to educational excellence, community engagement, and global connections, making it a vibrant part of the southeastern North Carolina community. UNCW also emphasizes the importance of freedom of expression and mutual respect within its diverse community.

Sonofii is an early-stage life science company focused on advancing the treatment of soft tissue infections and chronic wounds. Leveraging a proprietary dual dynamic technology, the company targets antibiotic-resistant and biofilm-associated infections to accelerate healing while aiming to lower healthcare costs. The solution is investigational and currently pre-FDA approval, demonstrated in clinical trials to offer high infection resolution rates, including for MDR pathogens like MRSA.

CellBios is a biotechnology company specializing in the design, development, and manufacturing of single-use bioprocessing and medical device solutions for healthcare, biotechnology, and regenerative medicine sectors. The company operates GMP and ISO-certified cleanroom facilities, offering a comprehensive portfolio of cryopreservation products, bioreactors, fluid management systems, advanced packaging, and specialty devices. By leveraging expertise in extrusion, molding, assembly, sterilization, quality control, and regulatory compliance, CellBios provides customized, scalable solutions to support blood transfusion, cell and gene therapy, biologics manufacturing, and clinical workflows.

The University of Missouri-Kansas City (UMKC) is dedicated to transforming today's learners into tomorrow's leaders through innovative education, research, and community engagement. With over 125 academic programs, UMKC fosters a diverse and inclusive environment that empowers students to achieve their goals and make a positive impact in their communities.

Mayo Clinic is the largest integrated, not-for-profit medical group practice in the world, dedicated to providing high-quality, patient-centered care. With a history of innovation spanning nearly 150 years, Mayo Clinic is committed to transforming healthcare through research, education, and compassionate care, ensuring that the best possible treatment is available to everyone.

New Horizon Medical Solutions is a national advanced wound-care platform delivering biologics, devices, diagnostics, clinical education, reimbursement support, and operational infrastructure to outpatient, post-acute, surgical, and wound-care providers. The company partners with leading manufacturers and healthcare organizations to support compliant adoption of advanced wound-care technologies across the full care continuum.

Adipothera develops therapies that repair damaged tissue rather than manage symptoms. We target the stromal microenvironment to address the underlying biology of fibrosis and tissue remodeling. Our lead program addresses radiation-induced skin injury across both medical countermeasure and oncology supportive care settings, with an expanding pipeline in lymphedema and pathological bone formation.

Temple University is Philadelphia’s only public university and a global center of academic excellence. It is classified as an R1 institution, indicating very high research activity, and offers over 600 academic programs across 17 diverse schools and colleges. The university is committed to providing accessible education that fosters positive change and prepares students to become leaders in their fields. Additionally, Temple emphasizes a vibrant campus life enriched by arts, culture, and a commitment to diversity and inclusivity. The university also promotes a tobacco-free environment to enhance the health and well-being of its community. Temple's athletics program further enhances student life, with 19 varsity teams competing at the NCAA Division I level, fostering school spirit and community engagement.

The Office of Sponsored Projects Administration (OSPA) at the University of Kentucky is dedicated to transforming tomorrow by streamlining grants and contracts. OSPA provides essential services to faculty and staff, including assistance with proposal preparation, award negotiation, and compliance with sponsor policies.

Southwest Research Institute (SwRI) is a nonprofit research and development organization that provides independent, premier services to government and industry clients. Founded in 1947, SwRI is committed to advancing science and technology to benefit humanity, focusing on innovative solutions that improve human health and safety. With a diverse range of technical divisions, SwRI addresses complex challenges in various fields including mechanical engineering, materials, aerospace, automotive, biomedical, and more.

Aroa Biosurgery Incorporated is wholly owned by Aroa Biosurgery Limited, a New Zealand-based healthcare company specializing in the development, manufacture, and distribution of advanced bioscaffold devices for soft tissue repair and wound management. Utilizing extracellular matrix (ECM) biomaterials, the company offers solutions for chronic wounds, surgical reconstruction, and dead-space management. Products are distributed internationally and supported by clinical evidence, regulatory approvals in 50+ countries, and a strong commercial presence in the US and Europe. The company maintains ISO 13485:2016 and MDSAP certifications and is publicly listed on the Australian Securities Exchange.

The University of Texas at Dallas (UT Dallas) is a top public research university located in Richardson, Texas, known for its innovative programs, renowned faculty, and a commitment to academic excellence. With over 31,000 students across seven schools, UT Dallas offers a diverse range of undergraduate and graduate programs designed to prepare students for leadership roles in various fields including science, engineering, business, and the arts. The university emphasizes research, community engagement, and student success, making it a vibrant hub for learning and innovation. Additionally, UT Dallas is recognized for its strong return on investment, high graduation rates, and successful career placement for graduates, with many students continuing their education at prestigious graduate schools.

The Israel Innovation Authority is the central governmental body responsible for fostering and advancing Israel's innovation ecosystem. Its mission is to power innovation through investment, insight, and impactful programs, supporting high-tech entrepreneurship, deep-tech ventures, and global collaborations. The Authority provides non-dilutive funding, strategic support, and regulatory guidance to startups and established companies, ensuring Israel remains a global leader in technology and innovation. With a focus on sectors such as AI, bioconvergence, foodtech, climate tech, and more, the Authority bridges academia, industry, and international partners to address humanity's pressing challenges and drive economic growth. Israel's tech ecosystem, often called the "Startup Nation," is characterized by a culture of bold experimentation, interdisciplinary collaboration, and resilience, making it a global powerhouse for innovation. The Authority also plays a pivotal role in shaping national innovation policy, supporting R&D, and facilitating co-investment opportunities for international investors. The Authority's unique features include proactive future-readiness, risk-absorbing investment models, global market integration, and resilience in times of crisis, such as the deployment of Fast-Track bridging funds to protect startups. The Authority also operates innovation centers and manufacturing accelerators to expand high-tech opportunities geographically and demographically, and regularly identifies and supports emerging technologies with high potential impact. The Authority supports a vast portfolio of startups and scale-ups across diverse sectors, including medical engineering, software, electronics, foodtech, biotech, and more, through programs such as Tnufa, Technological Incubators, R&D grants, and international collaborations.

Paracrine develops regenerative therapies for chronic wound care, leveraging autologous cell-based treatments and real-time AI platforms to enhance healing precision, predictability, and efficiency. The company operates globally, focusing on scalable and cost-effective biological solutions that integrate advanced machine learning for improved patient outcomes.

Nanomedicine Manufacturing Laboratory (NML) is a research and development laboratory specializing in nanomaterials and biomaterials for imaging, oxygen delivery, and drug delivery, with a core emphasis on scalable manufacturing and Quality-by-Design (QbD). More information about NML: https://www.duq.edu/research/faculty-research/nanomedicine-lab/nanomed-lab-research.php Led by Dr. Jelena M. Janjic, the Nanomedicine Manufacturing Laboratory develops colloidal nanosystems and implantable biomaterials that support molecular imaging modalities, including magnetic resonance imaging (MRI) and near-infrared fluorescence; biosensing, drug delivery; oxygen delivery; and theranostic nanomaterials, used for local and parenteral administration or as implantable biomaterials. A major barrier to the advancement of nanotechnology-based therapeutics is not conceptual innovation but manufacturability, cost, and quality control. The Nanomedicine Manufacturing Laboratory addresses these challenges by incorporating manufacturing process design, scalability, and quality control at the earliest stages of material design. Over the past decade, the laboratory has established robust, reproducible, and cost-effective nanomedicine manufacturing methods by applying QbD frameworks, enabling reliable scale-up and controlled performance. The laboratory’s work is supported by the U.S. Air Force, the Congressionally Directed Medical Research Programs (CDMRP), and ARPA-H through collaborative programs spanning academia, industry, and government. The Nanomedicine Manufacturing Laboratory operates at the intersection of materials science, manufacturing, and translational medicine, with a focus on developing innovative nanomedicines and biomaterials that translate into accessible, cost-effective future treatments for civilian and military medical needs.

The University of Arizona Applied Research Corporation (UA-ARC) is a non-profit organization affiliated with the University of Arizona, dedicated to leveraging the university's strengths in research and education to address national security challenges. UA-ARC aims to deliver innovative solutions and foster collaborations between academia, industry, and government.

The University of Utah (UU) is a leading research institution recognized for its research activity and commitment to innovation and discovery. As an R1 Institution, it is dedicated to advancing knowledge and solving critical problems that challenge our national security interests and impact the global community. We foster interdisciplinary collaboration and provide resources to drive transformative research focused on enhancing medical care superiority for the U.S. Department of Defense (DoD) through advanced medical and engineering research sponsored by our Applied Medical & Engineering Laboratory (AM&E Lab). As a leading public university, UU also provides healthcare services to seven states in the Intermountain West, with the largest catchment of remote and austere frontier territory for any academic center. Leveraging its geographic advantage, technological and commercialization strengths, expertise in medical services, and leading-edge, core engineering competencies, UU is uniquely positioned to address the nation's critical national security interests.

Spectral AI develops artificial intelligence-driven diagnostic solutions for wound management, with a focus on burns and diabetic foot ulcers. Utilizing multispectral imaging and advanced machine learning algorithms, the company provides objective, real-time predictions of wound healing potential to support clinical decision-making. Their technology improves accuracy in wound assessment, helping clinicians address diagnostic gaps and reducing subjectivity in care. Spectral AI’s solutions support both risk stratification and treatment planning, aiming to optimize outcomes and reduce healing-related complications.

The Institute for Biohealth Innovation (IBI) at George Mason University unites over 300 faculty and thousands of students across 34 departments to advance human health and well-being through innovative research. The IBI focuses on major health challenges, including infectious diseases, cancer, brain and behavior, and cardiovascular health, collaborating with national and international partners to implement solutions that enhance health outcomes.

The University of Minnesota's Research and Innovation Office (RIO) serves as a central resource for conducting, managing, and sponsoring research. It aims to facilitate collaborative research that addresses complex problems and promotes innovations that improve lives. RIO oversees research compliance and administration, fostering a culture of integrity and ethical practices in research. Additionally, RIO is committed to enhancing research capacity through various funding opportunities and strategic initiatives, including the management of specialized facilities for biocontainment research.

The University of Notre Dame, founded in 1842, is a prestigious Catholic research university located in South Bend, Indiana. It is dedicated to providing a holistic education that integrates faith, reason, and service to others. The university aims to be a leading global Catholic research institution, fostering a community of scholars committed to inquiry, justice, and the common good.

New York University (NYU) is a global university that connects talented and ambitious individuals in some of the world's greatest cities. Its mission is to be a top-quality institution, providing a diverse range of academic programs and opportunities for students to engage with the world's challenges. NYU is committed to fostering innovation and entrepreneurship, and it emphasizes diversity, equity, and inclusion in its educational mission. Founded in 1831, NYU has evolved to become a leader in higher education, with a commitment to accessibility and a diverse student body. NYU offers a wide array of academic programs, including accelerated studies and online education, catering to the needs of a global student population.

Remedor Biomed is a clinical research stage biopharmaceutical company focused on revolutionizing complex wound treatment through patented technology. The company aims to provide innovative solutions for diabetic foot ulcers and complex skin wound conditions, significantly impacting patients' lives and healthcare systems.

Aceso Plasma develops investigational cold plasma medical devices focused on wound care, dermatology, and defense decontamination applications. Their flagship handheld device generates non-thermal, localized plasma from ambient air, supporting accelerated wound healing and reducing microbial and biofilm burden without increasing antimicrobial resistance. The technology has been validated in pre-clinical and investigational studies at multiple independent research institutes, including military and academic partners, and is currently advancing towards FDA clearance.

Northwestern University is a prestigious institution dedicated to fostering a diverse and inclusive environment, promoting academic excellence, and engaging in impactful research. With campuses in Evanston, Chicago, and Doha, Qatar, Northwestern emphasizes global engagement and community involvement, preparing students to tackle complex challenges through interdisciplinary collaboration and innovative thinking.

The University of Iowa is dedicated to providing a comprehensive educational experience that fosters academic excellence, research opportunities, and a vibrant student life. With a commitment to accessibility and inclusivity, the university aims to prepare its students for success in various fields while promoting a supportive community.

Case Western Reserve University is dedicated to solving the biggest issues of today and tomorrow through innovative research and education. With a commitment to experiential learning, the university offers a wide range of programs and opportunities for students to engage in research, internships, and community service, all within a vibrant campus located in Cleveland, Ohio.

The University of Alaska Fairbanks (UAF) is a Land, Sea, and Space Grant university and an international center for research, education, and the arts, emphasizing the circumpolar North and its diverse peoples. UAF integrates teaching, research, and public service as it educates students for active citizenship and prepares them for lifelong learning and careers.

The University of South Florida (USF) is a Preeminent Research University and member of the Association of American Universities (AAU), dedicated to empowering students to maximize their potential for lifelong success. With campuses across the vibrant Tampa Bay region, USF serves nearly 50,000 students and offers a wide range of academic programs, innovative research opportunities, and a commitment to community engagement.

New Jersey Institute of Technology (NJIT) is a leading public research university dedicated to providing students with a world-class education in STEM fields and beyond. With a commitment to academic excellence, NJIT prepares students to be leaders in the most in-demand fields through innovative programs, expert faculty, and extensive research opportunities. NJIT is recognized for its affordability and return on investment, making it a top choice for students seeking a quality education. NJIT is also ranked among the top public universities in the nation, known for its diverse student body and commitment to fostering an inclusive environment.

The University of Arkansas for Medical Sciences Office of Research and Sponsored Programs (ORSP) is dedicated to supporting UAMS faculty in acquiring, performing, and administering projects funded by external sources. The ORSP ensures compliance with policies, negotiates award terms, liaises between investigators and sponsors, and manages subcontracts.

Modulim is dedicated to preventing the complications of chronic wounds due to diabetes, peripheral arterial disease, and burns. Mapping tissue health at the point-of-care is key to preventing non-healing chronic wounds. This is made possible only by Modulim's handheld microvascular imaging solution, powered by Spatial Frequency Domain Imaging (SFDI), that empowers healthcare teams with proprietary data and proactive, personalized AI insights.

Founded by Thomas Jefferson in 1819, the University of Virginia is a prestigious public university that emphasizes the advancement of human knowledge, education of leaders, and cultivation of an informed citizenry. It is recognized for its commitment to academic excellence, vibrant student life, and a strong alumni network, making it one of the top public universities in the United States.

The University of Missouri is dedicated to advancing research, innovation, and impact through a comprehensive support system for faculty, students, and staff. It aims to foster collaboration, enhance economic development, and promote entrepreneurship, while ensuring compliance with research regulations and ethical standards. The university also emphasizes the importance of interdisciplinary partnerships and provides resources to support veteran entrepreneurs through programs like the Entrepreneurship Bootcamp for Veterans.

Viscus Biologics LLC specializes in product realization from ideation to high volume production, manufacturing components, devices, and products with natural polymer and extracellular matrix materials. The company aims to fulfill patient and market needs, improve quality of life, and restore tissue to a healthy state.

MLM Biologics Inc. is dedicated to advancing wound care through innovative solutions like the bio-ConneKt® Wound Matrix, a collagen-based product designed for effective wound closure. The company emphasizes a mission of providing more effective and economical solutions for wound healing, aligning with the Gandhian Economic Principle of 'More for Less for Many.'

Regencor is a biotechnology company developing regenerative therapeutic solutions for cardiac repair following myocardial infarction. The organization advances a proprietary biologic that stimulates regeneration of heart muscle cells, aiming to restore cardiac function, reduce scar tissue, and prevent heart failure. The company emphasizes non-invasive, outpatient administration of its lead recombinant protein, with a translational approach guided by demonstrated preclinical efficacy and safety. Founded as a spin-out from Stanford University, Regencor is supported by grants from major institutions and has an experienced leadership and scientific advisory board.

The University of Massachusetts Lowell (UML) is dedicated to providing a comprehensive educational experience that prepares students for success in their careers and lives. With over 200 degree programs and a commitment to research and community engagement, UML fosters a vibrant learning environment for its diverse student body.

Lynch Regenerative Medicine specializes in regenerative biotherapeutics focusing on platelet-derived growth factor (PDGF) for wound healing, soft tissue, and bone regeneration. The company demonstrates expertise in recombinant protein engineering, clinical development, and regulatory submission of PDGF-based therapies for medical, dental, and aesthetic applications. The leadership is comprised of experts in growth factor science and translational medicine with an extensive record of scientific publication, patents, and FDA approvals.

Red Maple LifeSciences develops smart biomaterial solutions designed to improve the detection and treatment of wound infections by integrating bacteria-responsive hydrogels that enable real-time infection monitoring and targeted antimicrobial therapy.

The University of Nebraska Medical Center (UNMC) is dedicated to transforming lives through premier educational programs, innovative research, and extraordinary patient care. Founded in 1869, UNMC is a leader in health sciences education and research, serving as a vital resource for Nebraska and beyond.

The University of Georgia (UGA) is dedicated to facilitating instruction, scholarly and creative activity, and research collaborations across disciplines. UGA is a leader in research-based products and innovation, significantly impacting the state of Georgia and beyond through its extensive research initiatives and academic programs.

MassBiologics, part of UMass Chan Medical School, is the only nonprofit, FDA-licensed manufacturer of vaccines and biologics in the United States. With over 100 years of experience, it is dedicated to improving public health through the research, development, and production of biologic products, including vaccines and monoclonal antibodies.

The Medical University of South Carolina (MUSC) is South Carolina’s premier biomedical research institution, dedicated to advancing health through innovative research, education, and clinical care. With over $300 million in research funding and a commitment to addressing pressing health challenges, MUSC fosters collaboration among faculty, staff, and community partners to translate scientific discoveries into impactful health solutions. The South Carolina Clinical & Translational Research Institute (SCTR) at MUSC supports innovative research across the translational spectrum, from basic science to population health, including patient-centered and community-engaged research.

The University of Florida is a leading public university that fosters innovation, education, and research. With a commitment to excellence, the university provides a diverse and inclusive environment for students, faculty, and staff, driving impactful discoveries and community engagement.

The UCI Office of Research is dedicated to supporting and enhancing the creative and scholarly activities of UCI faculty and researchers. It provides central administrative support for research programs, ensuring compliance with regulations and fostering an environment conducive to research and innovation.

Caleo Biotechnologies develops patient-derived human translational models for preclinical therapeutic development. Our proprietary Organ-Dish™ platform generates multicellular 3D tissue models directly from human biospecimens while preserving key epithelial, stromal/mesenchymal, and immune compartments and features of native tissue biology. The platform enables evaluation of therapeutic efficacy, tissue injury and repair, inflammation, immune response, fibrosis and remodeling, and translational biomarkers in a patient-relevant human system. Organ-Dish™ models are scalable and compatible with pharmacologic, biologic, and cell-based therapeutic testing and downstream molecular and histologic analyses. Our approach aligns with the FDA’s increasing emphasis on human-relevant New Approach Methodologies (NAMs) to strengthen preclinical evidence and reduce reliance on animal testing. CaleoBio is interested in partnerships with therapeutic developers, biotechnology companies, academic investigators, and government/DoD teams seeking human translational models to support preclinical R&D and therapeutic development. Current and expanding applications include gastrointestinal disease, traumatic and complex wounds, pulmonary fibrosis, liver disease, and oncology.

Instant Systems specializes in the design and manufacture of single-use sterile systems for cell and gene therapy, regenerative medicine, tissue banking, and related bioprocessing applications. The company offers a wide range of customizable solutions for cell culturing, fluid management, media and waste containment, magnetic cell separation, and sterile filtration, with a focus on maintaining process integrity from production through delivery. Their products support closed-system workflows, scalability, and integration into existing manufacturing and research environments.

NuNexus Bio is an emerging medical-technology company advancing a portfolio of regenerative therapeutics and bio-detection platforms built to protect and restore the health of the warfighter and their families. Our founding team pairs two decades of medtech commercialization experience and biomaterials expertise with nearly a decade of federal acquisition service for military partners — a combination assembled to move promising early science across the hardest gap in translation: from the laboratory bench to a fielded, FDA-regulated product. Our regenerative medicine pipeline targets the musculoskeletal and traumatic injuries that drive lost duty days and long-term disability across the force. Lead programs include a tissue-penetrating hyaluronic acid technology that preserves injured cartilage and soft tissue near the point of injury, marine-collagen and extracellular-matrix scaffolds for bone and tissue repair to accelerate healing. In parallel, our bio-detection platform delivers rapid, low-cost colorimetric sensor arrays for detection at the point of need in austere, resource-constrained environments. Across every program, NuNexus is defined by the same disciplines: rigorous science developed with leading academic, scientific, VA and military research partners, a deliberate regulatory and manufacturing pathway, and a focus on capabilities that matter in pre-hospital and operational settings. As a non-traditional defense contractor and small business, we combine the agility to innovate quickly with the federal fluency to deliver responsibly — so better care reaches those who serve, and the families who stand behind them.

Virginia Tech is a leading research institution dedicated to improving the quality of life and the human condition through education, research, and community engagement. With a commitment to its motto, 'Ut Prosim' (That I May Serve), Virginia Tech fosters a collaborative environment that integrates technology into all disciplines, preparing scholars to be leaders and problem-solvers.

Clyra Medical Technologies is a healthcare company dedicated to improving lives by developing and commercializing innovative products for wound and skin infection treatment. As a subsidiary of BioLargo, Inc., Clyra focuses on creating safe, effective, and cost-efficient solutions that reduce the need for antibiotics and promote wound healing. Their technology, based on a copper-iodine complex, offers a broad-spectrum antimicrobial effect without known microbial resistance, making it suitable for various healthcare settings.

LSU Health Sciences Center New Orleans is dedicated to educating future health professionals and scientists, advancing research, and providing exceptional healthcare. With six professional schools and numerous affiliated hospitals, LSUHSC-NO aims to improve health outcomes and address health equity challenges in Louisiana.

Vira Regen is pioneering electrogenetics—a new class of bioelectronic medicine that uses precision electrical signals to modulate gene expression and activate the body’s natural regenerative pathways. Our platform is designed to move beyond conventional electrical stimulation by targeting specific genetic and biological pathways involved in tissue repair and regeneration. By combining bioelectric stimulation with computational biology, transcriptomic profiling, and signal discovery, Vira Regen is developing noninvasive therapies that can precisely influence cellular behavior at the site of injury. Our lead program, OsteoVolt™, is a noninvasive bioelectronic bone regeneration technology designed to accelerate healing of fresh and nonunion fractures. Preclinical studies have demonstrated accelerated bone regeneration and fracture healing, and the program is advancing through large-animal validation toward a Class II 510(k) regulatory pathway. Beyond bone regeneration, Vira Regen is building its electrogenetic therapeutic modality as a platform technology for regenerative medicine, with potential applications across musculoskeletal disease, osteoporosis, osteoarthritis, oncology, and healthy longevity. Our vision is to create a new generation of medicines that don't simply treat disease—they use the body's own biological signaling systems to regenerate and restore function.

The University of Texas Permian Basin (UTPB) offers a modern, affordable education in the heart of West Texas, focusing on student success and community impact. With a commitment to providing a diverse range of undergraduate and graduate programs, UTPB aims to empower students to achieve their academic and career goals while contributing positively to the region. UTPB also emphasizes professional development through innovative programs like the Coursera Career Academy and the Impact Behavioral Health Scholarship, which covers tuition and fees for graduate students in specific programs.

Imbed Biosciences is a privately held medical device company that specializes in the development of advanced devices for the treatment of burns, ulcers, and soft-tissue repair. The company is committed to providing innovative solutions that improve patient care and outcomes through its patented Microlyte® Matrix technology.

MediWound Ltd. is a global leader in next-generation enzymatic therapeutics focused on non-surgical tissue repair. The company specializes in the development, production, and commercialization of rapid and effective biologics that enhance existing standards of care, improve patient experiences, and reduce costs and unnecessary surgeries.

Northeastern University is a global research university founded in 1898, renowned for its experiential learning model, high-impact research, and deep partnerships. The university emphasizes innovative teaching and research that engage students, faculty, and alumni in solving real-world problems, fostering a dynamic and inclusive community across its 13 campuses worldwide.

The Edward Via College of Osteopathic Medicine (VCOM) is dedicated to preparing globally minded, community-focused osteopathic physicians to meet the needs of rural and medically underserved populations. VCOM emphasizes research to improve human health and offers a comprehensive medical education across its campuses in Virginia, South Carolina, Alabama, and Louisiana.

The Center for Combat Medicine and Battlefield (COMBAT) Research is a lab within the University of Colorado, Denver that is dedicated to solving the U.S. military’s toughest medical challenges by leading high-impact research, education, and innovation. The center collaborates with government, academic, and industry partners to turn military medical gains into better healthcare for all. It focuses on combat and deployment-related medical research, leveraging over 100 years of combined military experience to address current military medicine research gaps and translate solutions to civilian communities. The center also emphasizes the importance of education and mentorship in advancing the next generation of military physicians and researchers.

Rebel Medicine is a science-led pharmaceutical company dedicated to revolutionizing acute pain management by developing innovative, non-opioid solutions. Their mission is to create impactful products that improve patient outcomes and reduce healthcare costs. By leveraging novel drug delivery technologies, Rebel Medicine aims to provide effective pain management solutions that eliminate the need for opioids, thus addressing a significant unmet medical need in acute and postoperative pain management.

The University of Montana (UM) is a flagship public research university located in Missoula, Montana. Established in 1893, UM offers a wide range of undergraduate and graduate programs, emphasizing research, creativity, and community engagement. With a commitment to academic excellence and public service, UM aims to transform lives through education and research, fostering a diverse and inclusive environment for its students.

The University at Buffalo is a leading public research university and flagship of the SUNY System, recognized for its innovative research and commitment to societal impact. It aims to transform scientific and technological breakthroughs into global impact, addressing complex challenges through interdisciplinary collaboration.

UC San Francisco is a leading university dedicated to advancing health worldwide through preeminent biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care. With a commitment to public service, UCSF aims to innovate health care approaches for vulnerable populations and train the next generation of health professionals.

Brinter is a pioneering US-based MedTech firm focused on revolutionizing tissue engineering through the development of 3D bioprinted biocomposite regenerative implants, known as BioMods™, which aim to restore damaged tissue and replace conventional implants, launching in orthopedics/tendons and ligaments. The company driven by a team of visionary entrepreneurs and leading bioscientists and engineers.

The University of Pennsylvania (Penn), founded in 1740 by Benjamin Franklin, is a world-renowned Ivy League institution located in Philadelphia. Penn is dedicated to advancing knowledge, fostering innovation, and making a positive impact locally and globally. With a strong commitment to interdisciplinary research, academic excellence, and community engagement, Penn offers a diverse and inclusive environment for students, faculty, and staff. The university is recognized for its leadership in research, robust financial aid programs, and a tradition of civic involvement. Penn's strategic initiatives, such as Penn Forward, focus on reshaping education, research, and service to meet the challenges of a rapidly changing world. The university is also a leader in sustainability, aiming for carbon neutrality by 2042 and net-zero endowment emissions by 2050, and is home to a vibrant ecosystem of innovation, global engagement, and community partnership.

UTHealth Houston is Texas’ resource for health care education, innovation, scientific discovery, and excellence in patient care. Since 1972, UTHealth Houston has been dedicated to educating the next generation of health care professionals, advancing biomedical research and public health, and providing exceptional care to communities. With half a century of experience, it is one of the nation’s most comprehensive academic health centers, committed to advancing the quality of human life through education, research, and clinical practice.

Cook MyoSite, a subsidiary of Cook Group, has been advancing human muscle cell technology since 2002. Operating under ISO 9001:2015-certified quality standards, we specialize in primary human skeletal muscle-derived cells and fibro-adipogenic progenitors sourced from healthy donors and individuals with neuromuscular, metabolic, and rare disorders. Our offerings include custom cell procurement, specialized media formulations, and contract manufacturing services—supporting both academic research and clinical development in regenerative medicine. Beyond research tools, Cook MyoSite is pioneering autologous muscle-derived cell therapies. Our investigational product, iltamiocel, is currently in a Phase III clinical trial for fecal incontinence, demonstrating our commitment to translating cell-based science into real-world solutions. With expertise in GMP manufacturing, analytical testing, and tailored partnerships, we empower collaborators to accelerate innovation in musculoskeletal and neuromuscular health worldwide.

NeuEsse Inc. is dedicated to advancing skin health through innovative plant-based technologies. Their mission is to provide effective solutions for skin repair, addressing challenges such as severe burns, wounds, and trauma. Their flagship product, OmegaSkin™, is a human skin substitute made from soy protein, designed to enhance healing outcomes with minimal scarring. NeuEsse aims to meet the unmet needs in wound treatment, offering products that are sustainable, vegan-friendly, and require no special handling.

Positive Impact Alliance (Recharge Room) delivers evidence-based, science-backed wellness and recovery solutions for first responders, educators, and public servants in high-stress professions. Its signature Recharge Room combines multiple preventative and therapeutic modalities to support mental, emotional, and physical health, reducing burnout, improving recovery, and strengthening resilience. The Recharge Room program incorporates mobile and on-site wellness hubs as well as a robust digital platform, aiming to improve workforce longevity, morale, and overall well-being while supporting recruitment and retention strategies for organizations in public safety, education, and related sectors.

Oridivus is pioneering the development of the first FDA-approved oral wound healing therapy, with a mission to transform pediatric oral health outcomes. The company addresses critical unmet needs in oral surgery by accelerating healing, reducing pain, and minimizing opioid dependency, especially in young patients. Oridivus leverages advanced biomaterials and immunomodulatory compounds to provide faster, safer, and more effective recovery for procedures such as wisdom tooth extractions, cleft palate repairs, and oral trauma. Their vision is to improve quality of life for children and young adults, break the cycle of opioid dependency, and set new standards in oral wound care.

SUNY Upstate Medical University is a leading academic medical center in Central New York, dedicated to providing exceptional patient care, advancing medical research, and educating future healthcare professionals. As the region's only Level I trauma center and a Magnet recognized institution, Upstate is committed to delivering cutting-edge, life-saving treatments and fostering a compassionate, patient-centered environment. The university also plays a significant role in the community through outreach programs and is recognized as one of America's best large employers by Forbes.

Washington State University (WSU) is a public research university dedicated to improving lives by serving the public good. With a commitment to unlocking possibilities, WSU empowers students, faculty, and others to create a world where all people can thrive. The university offers a diverse range of academic programs across its six campuses and is recognized for its high research activity and community engagement.

Altrazeal Life Sciences Inc. is a specialty medical technology company dedicated to developing and commercializing innovative drug delivery systems. Their mission is to improve patient outcomes by providing comprehensive solutions for patients, providers, and payers. The company is known for its patented Altrazeal® Transforming Powder Dressing, which optimizes the wound healing environment and supports tissue repair.

UCLA is a leading public research university located in Los Angeles, California. It is renowned for its commitment to the creation, dissemination, preservation, and application of knowledge for the advancement of global society. With a rich history of academic and athletic excellence, UCLA offers a comprehensive environment that supports both academic and personal growth. The university is dedicated to fostering innovation and making a significant impact on the world through groundbreaking research and transformative practices.

Arizona State University (ASU) is a comprehensive public research university known for its commitment to inclusivity, excellence, and societal impact. ASU is dedicated to advancing research-based solutions for global challenges, fostering strong leadership, and providing quality education accessible to all learners. The university is recognized for its innovative approach to education and its efforts in sustainability, research, and community service. ASU exemplifies a new prototype for the American public research university, focusing on excellence, broad access to quality education, and meaningful societal impact.

KeriCure Medical is a woman-owned biotechnology company based in Tampa, FL, dedicated to providing advanced skin and wound care products to military and civilians. Since 2014, the company has provided advanced wound care to consumers, hospitals, military personnel and animals, helping to prevent infections and enhance wound healing. KeriCure's nanopolymer platform technology is optimally positioned for robust wound care that is simple, multi-use and effective.

The Vanderbilt School of Engineering is a globally recognized academic and research institution dedicated to producing leaders and innovators in engineering. With a commitment to solving grand challenges, the school offers a diverse range of undergraduate and graduate programs across multiple engineering disciplines, fostering a culture of collaboration and excellence.

Matregenix is a global leader in nanofiber technology, specializing in highly customizable nanofibrous materials for diverse applications, particularly in filtration and biomedical fields. The company is committed to pushing the boundaries of nanofiber technology through innovative platforms and state-of-the-art electrospinning machines, providing comprehensive contract development and manufacturing services to help manufacturers bring their innovations to market.

The Medical College of Wisconsin (MCW) is dedicated to transforming healthcare through innovative education, research, and patient care. With a focus on academic medicine, MCW aims to improve the health of communities by fostering a collaborative learning environment that integrates medical education with groundbreaking research and comprehensive patient care.

The University of California San Diego (UC San Diego) is a leading public research university located in La Jolla, California with over $1.79B in research expenditures. Known for its innovative and interdisciplinary approach, UC San Diego offers a wide range of undergraduate, graduate, and professional programs across various fields. UC San Diego is recognized for its contributions to research and innovation, particularly in areas such as national defense, energy, data science, climate science, health innovation, and artificial intelligence. We also have the nation's first undergraduate program promoting projects and start up devoted to National Security Innovation (4iNS).

UT Health San Antonio is dedicated to educating the next generation of health care professionals, conducting innovative research, and providing high-quality patient care. With a commitment to community service, the institution aims to improve health outcomes in South Texas and beyond through its six schools and numerous degree programs.

Crescel is a pioneering skincare company that integrates nature and science to heal the skin. Founded by master biochemist Peter J. Passalacqua, Crescel focuses on restoring skin health through innovative products that enhance the body's natural cellular repair processes, particularly leveraging the power of mitochondria.

Indiana University is dedicated to building a better future through education, research, and community engagement. With a commitment to academic excellence, IU offers a diverse range of programs across its nine campuses, fostering an inclusive environment for over 90,000 students from around the world. IU is also at the forefront of groundbreaking research, particularly in areas such as brain health and Alzheimer's disease.

Houston Methodist Academic Institute integrates advanced clinical research, education, and healthcare innovation with a focus on translating scientific discoveries into improved patient outcomes. The institute offers accredited graduate and postgraduate medical education, supports interdisciplinary research in major areas such as cancer, cardiology, neuroscience, transplant medicine, and regenerative medicine, and provides extensive infrastructure for digital health and medical technology development. Training and fellowship programs span from medical residencies and fellowships to doctoral and research-oriented positions, supported by collaborations with leading academic and industry partners. The institute leverages core technology platforms, simulation centers, and comprehensive educational pathways to foster future leaders in medicine and biomedical research.

Akthelia Pharmaceuticals is a pioneering biopharmaceutical company focused on developing therapeutics that enhance the body's innate defense mechanisms to combat debilitating diseases. The company targets mucosal barrier injury and epithelial integrity through a novel immunotherapeutic strategy. Its mission is to revolutionize treatment for diseases such as cancer, infection, and autoimmune disorders by leveraging the body's own microbial defense mechanisms.

UT Southwestern Medical Center is a premier academic medical institution dedicated to advancing medical science and improving health care through excellence in education, research, and patient care. The center is renowned for its collaborative environment that fosters innovation and discovery, housing distinguished faculty including Nobel Laureates. UT Southwestern is recognized for its groundbreaking research, comprehensive educational programs, and commitment to patient care, serving millions annually across its facilities.

Yale University, founded in 1701, is dedicated to expanding and sharing knowledge, inspiring innovation, and preserving cultural and scientific information for future generations. It engages with local and global communities to promote cultural understanding and improve the human condition.

Stanford University, founded nearly 150 years ago, is dedicated to educating students for lives of leadership and contribution with integrity. The university emphasizes advancing fundamental knowledge, cultivating creativity, and pioneering research for effective clinical therapies, while also focusing on societal impact and solutions.

The University of Tennessee, Knoxville is dedicated to advancing knowledge and understanding through research, scholarship, and creative work. The Office of Research, Innovation, and Economic Development supports faculty, staff, and students in developing competitive proposals and fostering a strong culture of research integrity, aiming to create a more just, prosperous, and sustainable world.

The Geneva Foundation is a 501(c)3 nonprofit established in 1993, dedicated to advancing military medicine through research, development, and education. With a commitment to ensuring optimal health for service members and the communities they serve, Geneva collaborates with various partners to drive innovative medical research and improve healthcare outcomes.

UC Davis, founded in 1908, is a top-tier public university located in California, known for its commitment to education, research, and public service. It offers a diverse range of academic programs and is recognized for its contributions to agriculture, veterinary medicine, and sustainability. The university fosters a collaborative environment that encourages innovation and inclusivity, aiming to enhance the lives of its students and the broader community. Additionally, UC Davis is strategically located in the heart of Northern California, providing easy access to major attractions, including beaches, wine country, and national parks.

Allvivo Vascular is a biomedical company dedicated to developing innovative tissue regenerative and antimicrobial technologies aimed at reducing infections associated with medical devices and wounds. With a commitment to improving patient outcomes and healthcare economics, Allvivo collaborates with partners to deliver more effective treatment options.

Thendor Therapeutics is an early-stage biotechnology company focused on developing therapies aimed at reversing, halting, and preventing fibrosis across multiple organ systems. Leveraging peptide-based drug discovery, the company's mission is to restore tissue function and improve patient outcomes in pulmonary, urological, and systemic fibrotic diseases. Through a combination of targeted pathway research, regenerative approaches, and platform innovation, Thendor Therapeutics seeks to address unmet needs in fibrotic disease, which currently lacks effective treatments.

The Center for Military Medicine Research (CMMR) at the University of Pittsburgh is dedicated to advancing medical research for wounded service members and their families. The center focuses on trauma, emergency, and critical care, leveraging the university's strengths in medical and engineering fields, and collaborating with Carnegie Mellon University's robotics and AI expertise. CMMR aims to enhance trauma care for warfighters and civilians, contributing to the defense innovation economy.

The Texas A&M Engineering Experiment Station (TEES) is a state agency and part of the Texas A&M University System, dedicated to improving lives through engineering research, workforce development, and technology transition. TEES collaborates with industry, academia, and government to provide innovative solutions to global technical challenges.